Fresenius | FRE - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Akzo Nobel EUR 2.61B 273M 2026-09
Alcon AG USD 2.78B 370M 2026-06
AstraZeneca USD 12.22B 4.04B 2026-06
BASF EUR 15.77B 1.16B 2026-06
Bayer EUR 10.04B 168M 2026-06
Beiersdorf EUR 4.19B 32M 2026-06
DaVita Healthcare Partners USD -765.1M 9.6M 2026-06
Demant DKK 10.79B 1.16B 2026-06
E.ON EUR 15.11B 2.6B 2026-06
Essilor EUR 12.52B 568M 2026-06
Fresenius EUR 5.23B 9M 2026-06
Fresenius Medical Care EUR 4.32B 20.7M 2026-06
Getinge SEK 7.03B 2.96B 2026-06
Givaudan CHF 3B 107M 2025-12
GlaxoSmithKline GBP 5.8B 468M 2026-06
GN Store Nord DKK 2.11B 51M 2026-06
GRIFOLS EUR 1.55B 94M 2026-06
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Lonza CHF 2.9B 184M 2025-06
Merck EUR 4.34B 249M 2026-06
Novartis USD 10.2B 912M 2026-06
Philips EUR 3.75B 147M 2026-06
Roche Holding CHF 18.9B 2.12B 2026-06
RWE EUR 1.96B 2.47B 2026-06
Sanofi EUR 9.92B 607M 2026-06
Smith & Nephew USD 2.59B 71M 2026-06